[Translation] A single-center, randomized, double-blind, placebo-controlled Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of single and multiple intravenous infusions of UP-818-CC injection in healthy Chinese subjects
主要目的 评价UP-818-CC注射液在中国健康成年受试者中单剂和多剂静脉输注给药的安全性和耐受性。
次要目的 评价UP-818-CC注射液在中国健康成年受试者中单剂和多剂静脉输注给药的药代动力学(PK)特征。
探索性目的 评价UP-818-CC注射液在中国健康成年受试者中的免疫原性。
[Translation] Primary objective To evaluate the safety and tolerability of single and multiple intravenous infusions of UP-818-CC injection in healthy Chinese adult subjects.
Secondary objective To evaluate the pharmacokinetic (PK) characteristics of single and multiple intravenous infusions of UP-818-CC injection in healthy Chinese adult subjects.
Exploratory objective To evaluate the immunogenicity of UP-818-CC injection in healthy Chinese adult subjects.